Bankruptcy & Restructuring News & Analysis — Conductor

Yellow Corporation Seeks Court Approval for $66.5M Property Sales to Central Transport and RAMAR

Conductor

Yellow Corporation seeks bankruptcy court approval for $66.5 million in property sales, including a $54.5 million deal with Central Transport and a $12 million agreement with RAMAR Land Corporation. The proposed sales follow an extensive marketing process and represent a significant step in the company's ongoing Chapter 11 proceedings.

Read more →


Mining Project Wind Down Holdings Seeks to Modify Litigation Trust Agreement Amid Committee Changes

Conductor

Mining Project Wind Down Holdings has filed an emergency motion to modify its litigation trust agreement following the resignation of a key oversight committee member. The motion seeks to allow operation with a single committee member after Touzi Capital, LLC became subject to litigation and receivership, marking a significant shift in the company's post-bankruptcy governance structure.

Read more →


Natera Seeks Court Declaration on Asset Purchase Agreement in Invitae Bankruptcy Case

Conductor

Natera Inc. has filed an adversary complaint in Invitae's bankruptcy case, seeking to prevent enforcement of a rejected Asset Purchase Agreement. The biotechnology company argues that Invitae's rejection of the contract in bankruptcy proceedings should bar any claims related to potential milestone payments, highlighting key issues in contract rejection under Chapter 11 bankruptcy law.

Read more →


Vintage Wine Estates Files Disclosure Statement in Delaware Bankruptcy Case

Conductor

Vintage Wine Estates has filed its disclosure statement in Delaware bankruptcy court, outlining a plan to consolidate 12 debtor entities and establish a liquidation trust. The plan projects 39% recovery for secured lenders and 5-8% for general unsecured creditors, following several successful asset sales to industry buyers.

Read more →


Biotech Firm Biora Therapeutics Moves to Reject Service Contracts in Chapter 11

Conductor

Biora Therapeutics, a San Diego biotech firm developing innovative oral drug delivery systems, has moved to reject seven service contracts in its Delaware bankruptcy case. The company, which filed Chapter 11 in December 2024, seeks to streamline operations while pursuing a sale of its assets. The targeted contracts include security systems, document storage, and facility maintenance services.

Read more →